Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia

JOVANOVIC JV; SCORE J; WAGHORN K; CILLONI D; GOTTARDI E; METZGEROTH G; ERBEN P; POPP H; WALZ C; HOCHHAUS A; ROCHE-LESTIENNE C; PREUDHOMME C; SOLOMON E; APPERLEY J; RONDONI M; OTTAVIANI E; MARTINELLI G; BRITO-BABAPULLE F; SAGLIO G; HEHLMANN R; CROSS NC; REITER A; GRIMWADE D